Apoptosis of Kinetin Riboside in Colorectal Cancer Cells Occurs by Promoting β-Catenin Degradation
7
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Kinetin riboside is a naturally produced cytokinin that displays strong antiproliferative activity in various human cancer cells. However, the mechanism of chemoprevention in colorectal cancer cells has not been elucidated. We used a cell-based reporter system to identify kinetin riboside as an antagonist of the Wnt/β-catenin pathway, which is aberrantly upregulated in colorectal cancer. Kinetin riboside suppressed β-catenin response transcription (CRT) by accelerating the degradation of intracellular β-catenin via a proteasomal degradation pathway. Pharmacological inhibition of glycogen synthase kinase-3β did not affect CRT downregulation. Kinetin riboside decreased the intracellular β-catenin levels in colorectal cancer cells with mutations in adenomatous polyposis coli (APC) and β-catenin. Consistently, kinetin riboside repressed expression of c-Myc and cyclin D1, βcatenin/T-cell factor (TCF)-dependent genes, and inhibited the proliferation of colorectal cancer cells. In addition, kinetin riboside stimulated apoptosis, as measured by an increase in annexin VFITC-stained cells. These findings suggest that kinetin riboside exerts its anti-cancer activity by promoting β-catenin degradation and has significant potential as a chemopreventive agent for colorectal cancer cells.
Abstract
Kinetin riboside is a naturally produced cytokinin that displays strong antiproliferative activity in various human cancer cells. However, the mechanism of chemoprevention in colorectal cancer cells has not been elucidated. We used a cell-based reporter system to identify kinetin riboside as an antagonist of the Wnt/β-catenin pathway, which is aberrantly upregulated in colorectal cancer. Kinetin riboside suppressed β-catenin response transcription (CRT) by accelerating the degradation of intracellular β-catenin via a proteasomal degradation pathway. Pharmacological inhibition of glycogen synthase kinase-3β did not affect CRT downregulation. Kinetin riboside decreased the intracellular β-catenin levels in colorectal cancer cells with mutations in adenomatous polyposis coli (APC) and β-catenin. Consistently, kinetin riboside repressed expression of c-Myc and cyclin D1, βcatenin/T-cell factor (TCF)-dependent genes, and inhibited the proliferation of colorectal cancer cells. In addition, kinetin riboside stimulated apoptosis, as measured by an increase in annexin VFITC-stained cells. These findings suggest that kinetin riboside exerts its anti-cancer activity by promoting β-catenin degradation and has significant potential as a chemopreventive agent for colorectal cancer cells.
참고문헌 (31)
- Wodarz A, "Mechanisms of Wnt signaling in development", Annu. Rev. Cell Dev. Biol, 14, pp.59~88 (1998)
- Huelsken J, "New aspects of Wnt signaling pathways in higher vertebrates", Curr. Opin. Genet. Dev, 11, pp.547~553 (2001)
- Miller JR, "The wnts", Genome Biology, 3, pp.1~15 (2001)
- Liu C, "Control of β-catenin phosphorylation", degradation by a dual-kinase mechanism, 2002, pp.108, 837~847
- Hart MJ, "Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3β", Curr. Biol, 8, pp.573~581 (1998)
- Ikeda S, "Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin", EMBO J, 17, pp.1371~1384 (1998)
- Aberle H, "β-catenin is a target for the ubiquitin–proteasome pathway", EMBO J, 16, pp.3797~3804 (1997)
- Hart M, "The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell", Curr. Biol, 9, pp.207~211 (1999)
- Giles RH, "Caught up in a Wnt storm: Wnt signaling in cancer", Biochim. Biophys. Acta, 1653, pp.1~24 (2003)
- Fearnhead NS, "The ABC of APC", Hum. Mol. Genet, 10, pp.721~733 (2001)
- Morin PJ, "β‐catenin signaling and cancer", Bioessays, 21, pp.1021~1030 (1999)
- He TC, "Identification of c-MYC as a target of the APC pathway", Science, 281, pp.1509~1512 (1998)
- He TC, "PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs", Cell, 99, pp.335~345 (1999)
- Tetsu O, "β-Catenin regulates expression of cyclin D1 in colon carcinoma cells", Nature, 398, pp.422~426 (1999)
- Barciszewski J, "Kinetin—a multiactive molecule", Int. J. Biol. Macromol, 40, pp.182~192 (2007)
- Griffaut B, "Cytotoxic effects of kinetin riboside on mouse, human and plant tumour cells", Int. J. Biol. Macromol, 34, pp.271~275 (2004)
- Ge L, "Identification of kinetin and kinetin riboside in coconut (Cocos nucifera L.) water using a combined approach of liquid chromatography–tandem mass spectrometry, high performance liquid chromatography and capillary electrophoresis", J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci, 829, pp.26~34 (2005)
- Shen M, "Betulinic acid induces ROS-dependent apoptosis and S-phase arrest by inhibiting the NF-κB pathway in human multiple myeloma", Oxid. Med. Cell. Longev, 2019, pp.5083158~ (2019)
- Dignam JD, "Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei", Nucleic Acids Res, 11, pp.1475~1489 (1983)
- Park S, "Hexachlorophene inhibits Wnt", β-catenin pathway by promoting Siahmediated β-catenin degradation, 2006, pp.70, 960~966
- Meijer L, "GSK-3-selective inhibitors derived from Tyrian purple indirubins", Chem. Biol, 10, pp.1255~1266 (2003)
- Ilyas M, "β-Catenin mutations in cell lines established from human colorectal cancers", Proc. Natil. Acad. Sci. USA, 94, pp.10330~10334 (1997)
- Roh H, "Suppression of β-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells", Cancer Res, 61, pp.6563~6568 (2001)
- Barker N, "Catenins, Wnt signaling and cancer", Bioessays, 22, pp.961~965 (2000)
- Cabello CM, "The experimental chemotherapeutic N6-furfuryladenosine (kinetin-riboside) induces rapid ATP depletion, genotoxic stress, and CDKN1A (p21) upregulation in human cancer cell lines", Biochem. Pharmacol, 77, pp.1125~1138 (2009)
- Rajabi M, "Antiproliferative activity of kinetin riboside on HCT-15 colon cancer cell line", Nucleosides, Nucleotides Nucleic Acids, 31, pp.474~481 (2012)
- Gwak J, "Small molecule-based promotion of PKCα-mediated β-catenin degradation suppresses the proliferation of CRT-positive cancer cells", PLoS One, 7, pp.e46697~ (2012)
- Zhang Y, "Genistein attenuates WNT signaling by up-regulating sFRP2 in a human colon cancer cell line", Exp. Biol. Med, 236, pp.714~722 (2011)
- Chen HJ, "The β-catenin", TCF complex as a novel target of resveratrol in the Wnt, Biochem. Pharmacol, pp.2012, 84[DOI]
- Ryu MJ, "Natural derivatives of curcumin attenuate the Wnt", β-catenin pathway through down-regulation of the transcriptional coactivator p300, 2008, pp.377, 1304~1308
- Park CH, "Quercetin, a potent inhibitor against β-catenin", Tcf signaling in SW480 colon cancer cells, 2005, pp.328, 227~234